Clinical Trial Update: A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

First-in-human study of alpha1H in patients with non-muscle invasive bladder cancer undergoing Phase 1/2 evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• alpha1H (alpha1H)

Snippet

Sponsor: Hamlet Pharma AB | Conditions: Non-muscle Invasive Bladder Cancer | Phase 1, Phase 2 | Status: UNKNOWN